Profile

ILIAS ELEFTHERIADIS

INTERVENTIONAL CARDIOLOGIST

DIRECTOR, 1ST CARDIOLOGY CLINIC OF INTERVENTIONAL CARDIOLOGY
  1. General
  2. Maternity - Gynecology
  • Education & Academic Titles
    • As. Professor of Medicine Section of Cardiology
      Loyola University Chicago, Stritch School of Medicine, Chicago, Illinois USA
    • As. Professor of Physiology
      Loyola University Chicago, Stritch School of Medicine, Chicago, Illinois USA
    • Senior Investigator
      Cardiovascular Institute, Loyola University, Stritch School of Medicine, Chicago, IL USA
    • 1995: American Board of Cardiovascular Disease
    • 1994-1995: Interventional Cardiology Fellow
      Loyola University Medical Center, Chicago, IL, USA
    • 1992: American Board of Internal Medicine
    • 1991-1994: Clinical Cardiology Fellow
      Loyola University Medical Center, Chicago, IL, USA
    • 1990- 1991: Resident in Internal Medicine University of Illinois Hospital, Chicago, IL, USA
    • 1988-1990: Resident in Internal Medicine Georgetown University και Veterans Affairs Medical Center, Washington DC, USA
    • 1986-1988: Postdoctoral Research Fellow
      National Institutes of Health (N.I.H), Diabetes Digestive and Kidney Diseases, Bethesda, MD, USA
    • 1980-1986: M.D. University of Ioannina School of Medicine, Ioannina, Greece
  • Doctoral Thesis

    1999: University of Ioannina School of Medicine, Ioannina, Greece
    “Metabolism and regulation of cardiac procollagen in hypertensive cardiomyopathy”

  • Professional Experience
    • 2002-2020: Director, Α’ Department of Cardiology Metropolitan General, Athens Greece
    • 1999-2002: Attending Interventional Cardiologist. Athens Medical Center, Athens Greece
    • 1996-1999: Director, Cardiac Catheterization Laboratory Edward Hines Jr.Veterans Affairs Medical Center, Chicago, IL USA
    • From 1995: As. Professor, Loyola University Medical Center, Stritch School of Medicine,
      Chicago, IL USA
  • Clinical Interest
    • Interventions in Coronary Artery Disease
    • Interventions in Structural Valvular and Congenital Heart Disease
  • Recent Publications
    • Kalantzi M, Eleftheriades E, Georgakis A, Theothoropoulos S, Yacoub M. Pulmonary valve replacement with aortic homograft. Hellenic J Cardiol. 46(2):148-9, 2005
    • Μαρία Β. Καλαντζή, Ηλίας Γ. Ελευθεριάδης, Απόστολος Σ. Γεωργάκης, Στέργιος Θεοδωρόπουλος, Magdi Yacoub: Αντικατάσταση Πνευμονικής Βαλβίδας με Ομοιομόσχευμα Αορτικής. Ελλ. Καρδιολογική Επιθεώρηση 46, 2: 148-149, 2005.
    • Iaffaldano, R.A., Jones, P., Lewis, B.E., Eleftheriades, E.G., Johnson, S.A., and McKiernan, T.L.. Percutaneous balloon pericardiotomy: A double balloon technique. Catheterization and Cardiovascular Diagnosis, (36): 79-81, 1995.
    • Karim, M.A., Farrar, M.A., Samarel, A.M., Eleftheriades, E.G., Reddy, B.H., Breland, C.M., and Miller, D.D. Histomorphometric and biochemical correlates of arterial procollagen gene expression during vascular repair after experimental angioplasty. Circulation, 91(7):2049-2057, 1995.
    • Eleftheriades, E.G., Ferguson, A.G., Spragia, M.L., and Samarel, A.M. Prolyl hydroxylation regulates intracellular procollagen degradation in cultured rat cardiac fibroblasts. J. of Mol. Cell. Cardiol., (27)1459-1473, 1995.
    • Qi, M., Ojamaa, K., Eleftheriades, E.G., Klein, I., and Samarel, A.M. Regulation of rat ventricular myosin heavy chain expression by serum and contractile activity. Am. J. of Physiol. 267 (Cell Physiol. 36): C520-C528, 1994.
    • Eleftheriades, E.G., Ferguson, A.G., and Samarel, A.M. Cyclosporine A has no effect on collagen metabolism by cardiac fibroblasts in vitro. Circulation 86: 1368-1377, 1993
    • Eleftheriades, E.G., Durand, J-B., Ferguson, A.G., Engelmann, G.L., Jones, S.B. and Samarel, A.M. Regulation of procollagen metabolism in the pressure-overloaded rat heart. J. Clin. Invest. 91: 1113-1122, 1993.
    • Eleftheriades, E.G., Qi, M., Sharp, W. and Samarel, A.M. Mechanochemical signal transduction, protein turnover and the pathogenesis of congestive heart failure. Heart Failure 8: 6, 266-274, 1992.
    • Boumpas, D.T., Eleftheriades, E.G., Molina, R., Barez, S., Atkinson, J., Older, S.A., Balow, J.E. and Tsokos, G.C. C-myc proto-oncogene expression in patients with primary sjogren’s syndrome. Arthritis Rheum. 33: 49-56, 1990.
    • Eleftheriades, E.G., Boumpas, D.T., Balow, J.E. and Tsokos, G.C. Transcriptional and post-transcriptional mechanisms are responsible for the increased c-myc oncogene expression in patients with systemic lupus erythematosus. Clin. Immunol. Immunopathol. 52: 507-515, 1989.
    • Boumpas, D.T., Eleftheriades, E.G., Barez, S. and Tsokos, G.C. Oncogene expression and regulation in normal lymphocytes and lymphocytes from patients with autoimmune diseases. Anticancer Research 8: 977-984, 1988.
    • Boumpas, D.T., Eleftheriades, E.G. and Tsokos, G.C. Cellular immunity in systemic lupus erythematosus. In Vivo 2: 41-46, 1988.
    • Siamopoulos, K.C., Eleftheriades, E.G., Pappas, M.V., Spheropoulos, G. and Tsolas, O. Ovine corticotropin-releasing hormone stimulation test in patients with chronic renal failure: Pharmacokinetic properties, and plasma adrenocorticotropic hormone and serum cortisol responses. Hormone Research 30: 17-21, 1988.
    • Boumpas, D.T., Tsokos, G.C., Mann, D.L., Eleftheriades, E.G., Harris, C.C. and Mark, G.E. Increased proto-oncogene expression in peripheral blood lymphocytes from patients with Systemic Lupus Erythematosus and other autoimmune diseases. Arthritis Rheum. 29: 755-760, 1986.
  • Membership in Societies and Editorial Boards

    Fellow of the American College of Cardiology (FACC)?